C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/51 (2006.01) A61K 38/16 (2006.01) A61K 39/29 (2006.01) C07H 21/00 (2006.01) C07K 14/18 (2006.01) C07K 16/10 (2006.01) C12N 15/63 (2006.01) C12P 21/02 (2006.01) C12Q 1/68 (2006.01) C12Q 1/70 (2006.01) G01N 33/569 (2006.01)
Patent
CA 2483289
A new virus, Hepatitis C virus (HCV), which has proven to be the major etiologic agent of blood-borne NANHH, was discovered by Applicant. The initial work on this virus, which includes a partial genomic sequence of the prototype HCV isolate, is described in EPO Pub. No. 318,216, and PCT Pub. No. .WO/89/04669. The present inven- tion, which in part is based on new HCV sequences and polypeptidee which are not disclosed in the above-cited publications, includes the application of these new sequences and polypeptides in immunoassays, probe diagnostics, anti-HCV antibody production, PCR technology, and recombinant DNA technology. Included within the invention also are novel immunogenic polypeptides encoded within clones containing HCV cDHA, novel methods for purifying an immunogenic HCV polypeptide, and antisense polynucleotides derived from HCV cDNA.
Choo Qui-Lim
Houghton Michael
Kuo George
Chiron Corporation
Novartis Vaccines And Diagnostics Inc.
Sim & Mcburney
LandOfFree
Hepatitis c diagnostics and vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hepatitis c diagnostics and vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatitis c diagnostics and vaccines will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2021119